Skip to content
2000
Volume 21, Issue 3
  • ISSN: 2666-0822
  • E-ISSN: 2666-0830

Abstract

Background

Bipolar disorder is a complex mental disorder with a multifactorial pathology. Meta-analyses have shown that bipolar disorder is associated with imbalanced oxidative status, which can contribute to disease progression. Therefore, restoring the oxidative imbalance could be beneficial in the treatment of bipolar disorder. The first-line pharmacotherapy for bipolar disorder is lithium, anticonvulsants (particularly sodium valproate), and atypical antipsychotics. In the present review, we sought to describe the effects of these first-line medications on oxidative stress in bipolar patients.

Methods

We systematically searched databases through January 2022, including the Web of Science, PubMed, Scopus, and Embase, with no language or time restrictions. Eligible articles that assessed oxidative markers in bipolar patients following standard pharmacotherapy were included.

Results

According to Newcastle Ottawa and NIH scales, the overall quality of the included articles was low, and their heterogeneity prevented us from performing a meta-analysis.

Conclusion

We found that standard medications, especially lithium, can potentially alleviate oxidative imbalance based on a reduction in oxidative markers, such as TBARs and MDA, although randomized clinical trials are needed to unequivocally confirm these results.

Loading

Article metrics loading...

/content/journals/cprr/10.2174/0126660822277544231207111352
2024-01-25
2025-05-08
Loading full text...

Full text loading...

References

  1. GrandeI. BerkM. BirmaherB. VietaE. Bipolar disorder.Lancet2016387100271561157210.1016/S0140‑6736(15)00241‑X 26388529
    [Google Scholar]
  2. GamaC.S. KunzM. MagalhãesP.V.S. KapczinskiF. Staging and neuroprogression in bipolar disorder: A systematic review of the literature.Rev. Bras. Psiquiatr.2013351707410.1016/j.rbp.2012.09.001 23567604
    [Google Scholar]
  3. BerkM. KapczinskiF. AndreazzaA.C. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors.Neurosci. Biobehav. Rev.201135380481710.1016/j.neubiorev.2010.10.001 20934453
    [Google Scholar]
  4. IslamM.T. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.Neurol. Res.2017391738210.1080/01616412.2016.1251711 27809706
    [Google Scholar]
  5. ScainiG. RezinG.T. CarvalhoA.F. StreckE.L. BerkM. QuevedoJ. Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.Neurosci. Biobehav. Rev.20166869471310.1016/j.neubiorev.2016.06.040 27377693
    [Google Scholar]
  6. BiswasS.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?Oxidat Med. Cell. Longevity20162016569893110.1155/2016/5698931
    [Google Scholar]
  7. SigitovaE. FišarZ. HroudováJ. CikánkováT. RabochJ. Biological hypotheses and biomarkers of bipolar disorder.Psychiatry Clin. Neurosci.20177127710310.1111/pcn.12476 27800654
    [Google Scholar]
  8. Cunha-OliveiraT. RegoA. OliveiraC. Oxidative stress and drugs of abuse: An update.Mini Rev. Org. Chem.201310432133410.2174/1570193X113106660026
    [Google Scholar]
  9. MansurR.B. RizzoL.B. SantosC.M. Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report.J. Psychiatr. Res.201680384410.1016/j.jpsychires.2016.05.014 27281261
    [Google Scholar]
  10. Fernández-SánchezA. Madrigal-SantillánE. BautistaM. Inflammation, oxidative stress, and obesity.Int. J. Mol. Sci.20111253117313210.3390/ijms12053117 21686173
    [Google Scholar]
  11. GiganteA.D. YoungL.T. YathamL.N. Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis.Int. J. Neuropsychopharmacol.20111481075108910.1017/S146114571000146X 21205433
    [Google Scholar]
  12. BrownN.C. AndreazzaA.C. YoungL.T. An updated meta-analysis of oxidative stress markers in bipolar disorder.Psychiatry Res.20142181-2616810.1016/j.psychres.2014.04.005 24794031
    [Google Scholar]
  13. Jiménez‐FernándezS. GurpeguiM. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta‐analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls.Bipolar Disord.2020
    [Google Scholar]
  14. AndreazzaA.C. Kauer-Sant’AnnaM. FreyB.N. Oxidative stress markers in bipolar disorder: A meta-analysis.J. Affect. Disord.20081112-313514410.1016/j.jad.2008.04.013 18539338
    [Google Scholar]
  15. Association AP Diagnostic and statistical manual of mental disorders: DSM-5.Washington, DCAmerican psychiatric association2013
    [Google Scholar]
  16. MoherD. ShamseerL. ClarkeM. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.Syst. Rev.2015411910.1186/2046‑4053‑4‑1 25554246
    [Google Scholar]
  17. Quality assessment tool for before-after (pre-post) studies with no control group.Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  18. WellsGA SheaB he Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.2000Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  19. IslamM.M. IqbalU. WaltherB. Benzodiazepine use and risk of dementia in the elderly population: A systematic review and meta-analysis.Neuroepidemiology2016473-418119110.1159/000454881 28013304
    [Google Scholar]
  20. BanerjeeU. DasguptaA. RoutJ.K. SinghO.P. Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorder.Prog. Neuropsychopharmacol. Biol. Psychiatry2012371566110.1016/j.pnpbp.2011.12.006 22230647
    [Google Scholar]
  21. de SousaR.T. ZanettiM.V. BusattoG.F. Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes.J. Psychiatr. Res.2014559610010.1016/j.jpsychires.2014.03.023 24768108
    [Google Scholar]
  22. AliyazicioğluR. KuralB. ÇolakM. KarahanS.C. AyvazS. DeğerO. Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder.Tohoku J. Exp. Med.20072131798710.1620/tjem.213.79 17785956
    [Google Scholar]
  23. LvQ. GuoY. ZhuM. Predicting individual responses to lithium with oxidative stress markers in drug-free bipolar disorder.World J. Biol. Psychiatry2019201077878910.1080/15622975.2019.1663929 31595816
    [Google Scholar]
  24. BengesserA.S. Mood stabilizers, oxidative stress and antioxidative defense in euthymia of bipolar disorder.CNS Neurol. Disord. Drug Targets2016154381389
    [Google Scholar]
  25. GarcíaS. AlberichS. MacDowellK.S. Association between medication adherence and oxidative stress in patients with first-episode mania.Front. Psychiatry20191016210.3389/fpsyt.2019.00162 30971964
    [Google Scholar]
  26. de SousaR.T. ZarateC.A.Jr ZanettiM.V. Oxidative stress in early stage bipolar disorder and the association with response to lithium.J. Psychiatr. Res.201450364110.1016/j.jpsychires.2013.11.011 24332923
    [Google Scholar]
  27. TiryakiA. AykutD.S. OzkorumakE. KarahanS.C. Comparison of levels of serum nitric oxide and asymmetric dimethylarginine levels in manic episodes in bipolar disorder before and after the treatment/Iki uclu duygudurum bozuklugunda tedavi oncesi ve tedavi sonrasi akut mani donemlerinde kan nitrik oksit ve asimetrik dimetil arginin duzeylerinin karsilastirilmasi.Anadolu Psikiyatri Derg.20171812936
    [Google Scholar]
  28. BahtiyarN BahtiyarN Serinkan CinemreFB Thyroid dysfunctions due to lithium treatment in bipolar disorder: Changes in oxidative stress, trace elements, and hemorheological parameters.J Elem202025(3/2020)10.5601/jelem.2020.25.1.1934
    [Google Scholar]
  29. Machado-VieiraR. ZanettiM.V. OtaduyM.C. Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder.J. Clin. Psychopharmacol.2017371404510.1097/JCP.0000000000000616 27902528
    [Google Scholar]
  30. Machado-VieiraR. AndreazzaA.C. VialeC.I. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects.Neurosci. Lett.20074211333610.1016/j.neulet.2007.05.016 17548157
    [Google Scholar]
  31. ChenJ.X. ZhangL.G. LiuK.Z. Patients with drug-naive bipolar disorder in remission after 8 weeks of treatment had decreased serum uric acid concentrations.Front. Psychiatry20191076710.3389/fpsyt.2019.00767 31736796
    [Google Scholar]
  32. KaleliogluT. GencA. KaramustafaliogluN. Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.Psychiatry Res.20142181-224925110.1016/j.psychres.2014.04.021 24768245
    [Google Scholar]
  33. BurnsP.B. RohrichR.J. ChungK.C. The levels of evidence and their role in evidence-based medicine.Plast. Reconstr. Surg.2011128130531010.1097/PRS.0b013e318219c171 21701348
    [Google Scholar]
/content/journals/cprr/10.2174/0126660822277544231207111352
Loading
/content/journals/cprr/10.2174/0126660822277544231207111352
Loading

Data & Media loading...

Supplements

PRISMA checklist is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test